CRUMLY & ASSOCIATES INC. GT Biopharma, Inc. Transaction History

CRUMLY & ASSOCIATES INC. portfolio value:

$0
portfolio value

CRUMLY & ASSOCIATES INC. quarter portfolio value change:

-41.14%
quarter

GT Biopharma, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -32.16K shares -96K $1.76 0
Q2 2022 share 0.00% 0 shares 3K $2.99 32.16K
Q1 2022 share 0.00% 0 shares 8K $2.88 32.16K
Q4 2021 share Increase 0.00% 32.16K shares 85K $3.17 32.16K